Code | CSB-RA560252A0HU |
Size | US$210 |
Order now | |
Image |
|
Have Questions? | Leave a Message or Start an on-line Chat |
Application | Recommended Dilution |
---|---|
WB | 1:500-1:5000 |
IHC | 1:50-1:200 |
FAAH is a membrane-bound serine hydrolase located in the brain and liver that is responsible for the hydrolysis and inactivation of the fatty acid amide family of signaling lipids, including the endocannabinoid anandamide. Genetic or pharmacological inactivation of FAAH enzyme leads to analgesic, anti-inflammatory, anxiolytic, and antidepressant effects in animal models, without producing the undesirable side effects observed with cannabinoid receptor agonists. FAAH represents therefore an attractive therapeutic target for the treatment of several central nervous system disorders involving pain, anxiety, and depression.
Compared with the polyclonal and monoclonal antibodies of FAAH, this FAAH recombinant antibody has the features of increased reproducibility and control, animal-free technology, high degree of monovalency, high batch-to-batch consistency, easier isotype conversion, etc. And it has been validated in ELISA, WB, IHC.There are currently no reviews for this product.